Terms: = Endocrine gland cancer AND MYC, c-Myc, 4609, ENSG00000136997
1287 results:
1. Effect of myc and PARP Inhibitors in Ovarian cancer Using an
Morea A; Saravi S; Sisu C; Hall M; Tosi S; Karteris E; Storlazzi CT
Anticancer Res; 2024 May; 44(5):1817-1827. PubMed ID: 38677725
[TBL] [Abstract] [Full Text] [Related]
2. Development, synthesis and validation of improved c-myc/Max inhibitors.
Yıldırım S; Kocabaş F; Mermer A
J Cell Mol Med; 2024 Apr; 28(8):e18272. PubMed ID: 38568057
[TBL] [Abstract] [Full Text] [Related]
3. Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms.
Agostini A; Piro G; Inzani F; Quero G; Esposito A; Caggiano A; Priori L; Larghi A; Alfieri S; Casolino R; Scaglione G; Tondolo V; Cammarota G; Ianiro G; Corbo V; Biankin AV; Tortora G; Carbone C
Nat Commun; 2024 Mar; 15(1):2764. PubMed ID: 38553466
[TBL] [Abstract] [Full Text] [Related]
4. EIF2Ss, a Novel c-myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic Adenocarcinoma.
Cao Z; Jing Y; Cheng C; Wang F; Guan M; Zhang K; Jiao J; Ruan L; Chen Z
Front Biosci (Landmark Ed); 2024 Mar; 29(3):119. PubMed ID: 38538250
[TBL] [Abstract] [Full Text] [Related]
5. Complexity of the Genetic Background of Oncogenesis in Ovarian cancer-Genetic Instability and Clinical Implications.
Murawski M; Jagodziński A; Bielawska-Pohl A; Klimczak A
Cells; 2024 Feb; 13(4):. PubMed ID: 38391958
[TBL] [Abstract] [Full Text] [Related]
6. Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level.
Perkiö A; Pradhan B; Genc F; Pirttikoski A; Pikkusaari S; Erkan EP; Falco MM; Huhtinen K; Narva S; Hynninen J; Kauppi L; Vähärautio A
Sci Rep; 2024 Feb; 14(1):4322. PubMed ID: 38383551
[TBL] [Abstract] [Full Text] [Related]
7. Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer.
Dash S; Ueda T; Komuro A; Honda M; Sugisawa R; Okada H
Cell Death Dis; 2024 Feb; 15(2):131. PubMed ID: 38346958
[TBL] [Abstract] [Full Text] [Related]
8. Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided Optimization.
Bauer N; Balourdas DI; Schneider JR; Zhang X; Berger LM; Berger BT; Schwalm MP; Klopp NA; Siveke JT; Knapp S; Joerger AC
ACS Chem Biol; 2024 Feb; 19(2):266-279. PubMed ID: 38291964
[TBL] [Abstract] [Full Text] [Related]
9. The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance.
Gu J; Zhang J; Xia R; Wang X; Yang J; Xie F; Zhou Q; Li J; Zhang T; Chen Q; Fan Y; Guo S; Wang H
Drug Resist Updat; 2024 Mar; 73():101027. PubMed ID: 38290407
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models.
Miao T; Symonds A; Hickman OJ; Wu D; Wang P; Lemoine N; Wang Y; Linardopoulos S; Halldén G
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279262
[TBL] [Abstract] [Full Text] [Related]
11. The radiation- and chemo-sensitizing capacity of diclofenac can be predicted by a decreased lactate metabolism and stress response.
Schwab M; Dezfouli AB; Khosravi M; Alkotub B; Bauer L; Birgani MJT; Multhoff G
Radiat Oncol; 2024 Jan; 19(1):7. PubMed ID: 38229111
[TBL] [Abstract] [Full Text] [Related]
12. NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1.
Zhang Z; Song B; Wei H; Liu Y; Zhang W; Yang Y; Sun B
Drug Resist Updat; 2024 Mar; 73():101040. PubMed ID: 38228036
[TBL] [Abstract] [Full Text] [Related]
13. LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-myc.
Liu J; Zhu Y; Wang H; Han C; Wang Y; Tang R
Cancer Sci; 2024 Mar; 115(3):804-819. PubMed ID: 38182548
[TBL] [Abstract] [Full Text] [Related]
14. "Quadruple-hit" primary testicular diffuse large B-cell lymphoma with MYD88 L265P mutation, IGH::myc, and IRF4- and BCL6-rearrangements.
Bruehl FK; Ketterling RP; Rimsza LM; Santos EF; McPhail ED
J Hematop; 2023 Sep; 16(3):161-165. PubMed ID: 38175404
[TBL] [Abstract] [Full Text] [Related]
15. Tumour-associated macrophages and Schwann cells promote perineural invasion via paracrine loop in pancreatic ductal adenocarcinoma.
Zhang B; Guo X; Huang L; Zhang Y; Li Z; Su D; Lin L; Zhou P; Ye H; Lu Y; Zhou Q
Br J Cancer; 2024 Mar; 130(4):542-554. PubMed ID: 38135712
[TBL] [Abstract] [Full Text] [Related]
16. Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma.
Hadoux J; Al Ghuzlan A; Lamartina L; Bani MA; Moog S; Attard M; Scoazec JY; Hartl D; Aldea M; Friboulet L; Jules-Clement G; Italiano A; Besse B; Lacroix L; Baudin E
JCO Precis Oncol; 2023 Sep; 7():e2300053. PubMed ID: 38127829
[TBL] [Abstract] [Full Text] [Related]
17. Aneuploidy Landscape in Precursors of Ovarian cancer.
Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM
Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050
[TBL] [Abstract] [Full Text] [Related]
18. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian cancer.
Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
[TBL] [Abstract] [Full Text] [Related]
19. Epigallocatechin gallate inhibits ovarian cancer cell growth and induces cell apoptosis via activation of FOXO3A.
Zhang Z; Zhang Q; Yu Y; Su S
In Vitro Cell Dev Biol Anim; 2023 Dec; 59(10):739-746. PubMed ID: 38038884
[TBL] [Abstract] [Full Text] [Related]
20. Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/myc signaling and restoring chemosensitivity.
Zheng Q; Tang J; Aicher A; Bou Kheir T; Sabanovic B; Ananthanarayanan P; Reina C; Chen M; Gu JM; He B; Alcala S; Behrens D; Lawlo RT; Scarpa A; Hidalgo M; Sainz B; Sancho P; Heeschen C
J Exp Clin Cancer Res; 2023 Nov; 42(1):323. PubMed ID: 38012687
[TBL] [Abstract] [Full Text] [Related]
[Next]
